Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants

OBJECTIVE: Report clinical response to recombinant factor VIIa in a cohort of critically ill infants. STUDY DESIGN: We identified all infants who received factor VIIa in the Duke Neonatal Intensive Care Unit between January 2005 and July 2008. Hematologic data and volume of blood transfusions before...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dang, Chi N, Katakam, Lakshmi I, Smith, P Brian, Cotten, C Michael, Goldberg, Ronald N, Chandler, Nicole, Thornburg, Courtney D, Bidegain, Margarita
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2972386/
https://ncbi.nlm.nih.gov/pubmed/20671714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jp.2010.85
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller